Revolution Medicines, Inc. (RVMD) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RVMDRevolution Medicines, Inc.Follow RVMD — free
—
Price chart with a free account
- Market cap
- 40.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 10 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -257.5% | -639.7% | -730.0% | -4207.1% | — | — | — | |
| Net margin | -251.6% | -636.6% | -703.0% | -3768.3% | — | — | — | |
| FCF margin | -239.6% | -523.0% | -664.8% | -3094.1% | — | — | — |
USD billions · SEC XBRL
Every figure on this page comes from Revolution Medicines, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.